APIMEDS PHARMACEUTICALS US INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$3.01
-6.23%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-26.6%
3 months
-37.9%
6 months
-84.0%
1 year
-85.3%
Year to date
-81.7%
52-week range
$1.60 – $38.95
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$4.5M
P/E
-0.1
P/B
0
P/S
—
Revenue
$0
Net income
-$58.17M
Diluted EPS
-36.57
Gross margin
—
Net margin
—
Return on equity
-59.00%
Total debt
$14.58M
Cash
$8.28M
Free cash flow
-$13.35M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$20.17M | — | — | -$5.67M |
| Mar 31, 2026 | $0 | -$35.06M | — | — | -$2.08M |
| Dec 31, 2025 | $0 | -$1.16M | — | — | -$3.86M |
| Sep 30, 2025 | $0 | -$1.78M | — | — | -$1.75M |
| Jun 30, 2025 | $0 | -$2.66M | — | — | -$3.37M |
| Mar 31, 2025 | $0 | -$402.4K | — | — | -$20.31K |
| Dec 31, 2024 | $0 | -$311.63K | — | — | -$99.62K |
| Sep 30, 2024 | $0 | -$332.52K | — | — | -$186.76K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent APUS news
All market newsNo ticker-linked stories are in the current archive.